Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
July 12, 2016
Patent Application Number
13824423
Date Filed
September 28, 2011
Patent Citations Received
Patent Primary Examiner
Patent abstract
Use of a chimeric protein selected from the group consisting of CTLA4-FasL and CD40-FasL proteins for treatment of lymphoma and/or a multiple myeloma and/or a leukemia as described herein, and pharmaceutical compositions and methods of treatment thereof.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
